SUN Pharmaceutical Industries Limited Pazopanib Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Pazopanib Export Records India — #1 Exporter, 9 Shipments, $450.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Pazopanib

India Pharmaceutical Trade Intelligence

$8.3M109 Suppliers57 CountriesHS 30049049

ExportsIndia → UNITED STATES84.4%India → GEORGIA2.6%

ImportsUNITED KINGDOM → India$3.3M SWITZERLAND → India$596.6K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

SUN Pharmaceutical Industries Limited — Pazopanib Exporter #1 | $450.0K Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Pazopanib Exporter Profile

Indian Pharmaceutical Exporter · #1 for Pazopanib · $450.0K export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Pazopanib with $450.0K in export value and 9 verified shipments. SUN Pharmaceutical Industries Limited holds a 5.4% market share in Pazopanib exports across 2 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Pazopanib Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Pazopanib export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Pazopanib?

Country	Value	Shipments	Share
UNITED STATES	$2.5M	51	72.9%
GEORGIA	$212.9K	12	6.1%
SRI LANKA	$161.5K	15	4.6%
TAIWAN	$100.0K	2	2.9%

Who Are the Top Buyers of Pazopanib from India?

Buyer	Country	Value	Orders
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$300.0K	6
M/S.NOVUGEN ONCOLOGY SDN.BHD	UNITED STATES	$282.3K	6
STATE PHARMACEUTICALS CORPORATION	SRI LANKA	$156.6K	4
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$150.0K	3
LOTUS PHARMACEUTICAL CO.LTD.,	TAIWAN	$100.0K	2
TISHAS ADDITIONAL LIABILITY COMPANY	BELARUS	$100.0K	2
STR INTERNATIONAL TRADING CO., LTD	THAILAND	$50.8K	3
142 DAVIT	GEORGIA	$42.2K	2
MERMISI LLC	GEORGIA	$27.1K	5
AYGUN PHARMA	AZERBAIJAN	$18.3K	3

India's Pazopanib is purchased by 196 buyers worldwide. The top buyer is SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES), followed by M/S.NOVUGEN ONCOLOGY SDN.BHD and STATE PHARMACEUTICALS CORPORATION.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Pazopanib Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$450.0K	9	2	$50.0K
2	SP ACCURE LABS PRIVATE LIMITED	$300.0K	6	2	$50.0K
3	TEYRO LABS PRIVATE LIMITED	$282.3K	6	1	$47.1K

SUN Pharmaceutical Industries Limited ranks #1 among 109 Indian Pazopanib exporters. Average shipment value of $50.0K compared to the market average of $13.8K. The closest competitors by value are SP ACCURE LABS PRIVATE LIMITED and TEYRO LABS PRIVATE LIMITED.

Which Indian Ports Ship Pazopanib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	121	24.3%
SAHAR AIR	103	20.7%
DELHI AIR	48	9.6%
DELHI AIR CARGO ACC (INDEL4)	41	8.2%
Bombay Air	23	4.6%
CHENNAI AIR CARGO ACC (INMAA4)	20	4.0%
CHENNAI AIR	18	3.6%
Bombay Air Cargo	16	3.2%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Pazopanib Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Pazopanib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 57+ countries, 196+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Pazopanib

Pazopanib

SUN Pharmaceutical Industries Limited — Pazopanib Exporter Profile

SUN Pharmaceutical Industries Limited — Pazopanib Export Profile: Buyers & Destinations

Where Does India Export Pazopanib?

Who Are the Top Buyers of Pazopanib from India?

What Is India's Total Pazopanib Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Pazopanib Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Pazopanib Exporters?

Regulatory Requirements: Exporting Pazopanib to Key Markets

United States — FDA

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Pazopanib Exporters?

Which Indian Ports Ship Pazopanib Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Pazopanib Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Pazopanib Export Data from SUN Pharmaceutical Industries Limited

Pazopanib Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source